Why CRISPR Therapeutics Stock Crushed the Market Today
The Motley Fool
NOVEMBER 7, 2023
Leading gene therapy company CRISPR Therapeutics (NASDAQ: CRSP) had quite the memorable day on the market Tuesday. Following the release of encouraging quarterly results, bulls ran rampant on the stock, and it closed almost 14% higher. Meanwhile, the bellwether S&P 500 index could only muster a 0.3% bump today. A notably narrower net loss in CRISPR's third quarter CRISPR, which is a relatively early-stage company with sporadic revenue, did not record any take on the top line in its third qua
Let's personalize your content